Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model.

Published

Journal Article

The current lack of diagnostic and prognostic biomarkers for traumatic brain injury (TBI) confounds treatment and management of patients and is of increasing concern as the TBI population grows. We have generated plasma proteomic profiles from mice receiving TBI by controlled cortical impact at either 1.3 mm or 1.8 mm depth, comparing these against those of sham injured-animals to identify plasma biomarkers specific to mild or severe TBI at 24 hours, 1 month, or 3 months post-injury. To identify possible prognostic biomarkers, we used apolipoprotein E (APOE)3 and APOE4 transgenic mice, which demonstrate relatively favorable and unfavorable outcomes respectively, following TBI. Using a quantitative proteomics approach (isobaric tagging for relative and absolute quantitation--iTRAQ) we have identified proteins that are significantly modulated as a function of TBI and also in response to the TBI*APOE genotype interaction, the latter representing potential prognostic biomarkers. These preliminary data clearly demonstrate plasma protein changes that are not only injury dependent but also interaction dependent. Importantly, these results demonstrate the presence of TBI-dependent and interaction-dependent plasma proteins at a 3-month time point, which is a considerable time post-injury in the mouse model, and will potentially be of significance for combat veterans receiving assessment at extended periods post-injury. Furthermore, our identification of clusters of functionally related proteins indicates disturbance of particular biological modules, which potentially increases their value beyond that of solitary biomarkers.

Full Text

Cited Authors

  • Crawford, F; Crynen, G; Reed, J; Mouzon, B; Bishop, A; Katz, B; Ferguson, S; Phillips, J; Ganapathi, V; Mathura, V; Roses, A; Mullan, M

Published Date

  • January 2012

Published In

Volume / Issue

  • 29 / 2

Start / End Page

  • 246 - 260

PubMed ID

  • 21895520

Pubmed Central ID

  • 21895520

Electronic International Standard Serial Number (EISSN)

  • 1557-9042

International Standard Serial Number (ISSN)

  • 0897-7151

Digital Object Identifier (DOI)

  • 10.1089/neu.2011.1789

Language

  • eng